Seip K - Search Results

1

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors.

Seip K, Fleten KG, Barkovskaya A, Nygaard V, Haugen MH, Engesæter BØ, Mælandsmo GM, Prasmickaite L. Seip K, et al. Oncotarget. 2016 Apr 12;7(15):19997-20015. doi: 10.18632/oncotarget.7671. Oncotarget. 2016. PMID: 26918352 Free PMC article.

2

Stroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment.

Seip K, Jørgensen K, Haselager MV, Albrecht M, Haugen MH, Egeland EV, Lucarelli P, Engebraaten O, Sauter T, Mælandsmo GM, Prasmickaite L. Seip K, et al. Cancer Lett. 2018 Dec 28;439:1-13. doi: 10.1016/j.canlet.2018.09.023. Epub 2018 Sep 18. Cancer Lett. 2018. PMID: 30240588

3

AXL inhibition improves BRAF-targeted treatment in melanoma.

Nyakas M, Fleten KG, Haugen MH, Engedal N, Sveen C, Farstad IN, Flørenes VA, Prasmickaite L, Mælandsmo GM, Seip K. Nyakas M, et al. Among authors: seip k. Sci Rep. 2022 Mar 24;12(1):5076. doi: 10.1038/s41598-022-09078-z. Sci Rep. 2022. PMID: 35332208 Free PMC article.

4

O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.

Barkovskaya A, Seip K, Hilmarsdottir B, Maelandsmo GM, Moestue SA, Itkonen HM. Barkovskaya A, et al. Among authors: seip k. Sci Rep. 2019 Apr 5;9(1):5670. doi: 10.1038/s41598-019-42153-6. Sci Rep. 2019. PMID: 30952976 Free PMC article.

5

Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen.

Barkovskaya A, Goodwin CM, Seip K, Hilmarsdottir B, Pettersen S, Stalnecker C, Engebraaten O, Briem E, Der CJ, Moestue SA, Gudjonsson T, Maelandsmo GM, Prasmickaite L. Barkovskaya A, et al. Among authors: seip k. Mol Oncol. 2021 Aug;15(8):2026-2045. doi: 10.1002/1878-0261.12951. Epub 2021 May 1. Mol Oncol. 2021. PMID: 33759347 Free PMC article.

6

Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells.

Barkovskaya A, Seip K, Prasmickaite L, Mills IG, Moestue SA, Itkonen HM. Barkovskaya A, et al. Among authors: seip k. Sci Rep. 2020 Oct 12;10(1):16992. doi: 10.1038/s41598-020-74083-z. Sci Rep. 2020. PMID: 33046784 Free PMC article.

7

EMT-Derived Alterations in Glutamine Metabolism Sensitize Mesenchymal Breast Cells to mTOR Inhibition.

Karvelsson ST, Sigurdsson A, Seip K, Grinde MT, Wang Q, Johannsson F, Mælandsmo GM, Moestue SA, Rolfsson O, Halldorsson S. Karvelsson ST, et al. Among authors: seip k. Mol Cancer Res. 2021 Sep;19(9):1546-1558. doi: 10.1158/1541-7786.MCR-20-0962. Epub 2021 Jun 4. Mol Cancer Res. 2021. PMID: 34088869

8

Semi-automated set-up for exhaustive micro-electromembrane extractions of basic drugs from biological fluids.

Dvořák M, Seip KF, Pedersen-Bjergaard S, Kubáň P. Dvořák M, et al. Among authors: seip kf. Anal Chim Acta. 2018 Apr 16;1005:34-42. doi: 10.1016/j.aca.2017.11.081. Epub 2017 Dec 28. Anal Chim Acta. 2018. PMID: 29389317

9

Micro-electromembrane extraction using multiple free liquid membranes and acceptor solutions - Towards selective extractions of analytes based on their acid-base strength.

Kubáň P, Seip KF, Gjelstad A, Pedersen-Bjergaard S. Kubáň P, et al. Among authors: seip kf. Anal Chim Acta. 2016 Nov 2;943:64-73. doi: 10.1016/j.aca.2016.09.022. Epub 2016 Sep 21. Anal Chim Acta. 2016. PMID: 27769378

10

Proteomics tools reveal startlingly high amounts of oxytocin in plasma and serum.

Brandtzaeg OK, Johnsen E, Roberg-Larsen H, Seip KF, MacLean EL, Gesquiere LR, Leknes S, Lundanes E, Wilson SR. Brandtzaeg OK, et al. Among authors: seip kf. Sci Rep. 2016 Aug 16;6:31693. doi: 10.1038/srep31693. Sci Rep. 2016. PMID: 27528413 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page